Madagascar vs Mauritania: Number of HIV positive pregnant women receiving antiretrovirals
Madagascar
106
in 2011
Mauritania
25
in 2011
Madagascar rank
34th
Mauritania rank
36th
Number of HIV positive pregnant women receiving antiretrovirals over time
- Madagascar
- Mauritania
How they compare
Madagascar currently reports 106 against 25 in Mauritania, a difference of 81.
That makes Madagascar's figure about 4.2 times Mauritania's.
The two have swapped places 1 time across 5 shared years of data; in 2005 it was Mauritania ahead.
Madagascar ranks 34th and Mauritania ranks 36th of 38 countries.
Across the 2 decades both report, Madagascar averaged higher in 1 and Mauritania in 1.
Head to head by decade
| Decade | Madagascar | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.25 | 33.75 | 19.5 | Mauritania |
| 2010s | 106 | 25 | 81 | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of hiv positive pregnant women receiving antiretrovirals, Madagascar or Mauritania?
- Madagascar, at 106 against 25 in Mauritania as of 2011.
- What is the difference in number of hiv positive pregnant women receiving antiretrovirals between Madagascar and Mauritania?
- 81, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Mauritania?
- 5 years are reported by both, from 2005 to 2011.
- How do Madagascar and Mauritania rank globally for number of hiv positive pregnant women receiving antiretrovirals?
- Madagascar ranks 34th and Mauritania ranks 36th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as Number of HIV positive pregnant women receiving antiretrovirals. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.